Acumen Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	177	222	221	274
Market Cap Growth	46.09%	0.62%	-19.22%	-
Enterprise Value	-50	10	43	79
PE Ratio	-	-4.25	-5.16	-2.72
PB Ratio	0.66	0.83	1.17	1.22
P/FCF Ratio	-4.79	-5.16	-6.26	-15.20
P/OCF Ratio	-4.79	-5.16	-6.29	-15.23
EV/EBITDA Ratio	-0.39	-0.19	-1.02	-0.79
EV/EBIT Ratio	-0.39	-0.19	-1.01	-0.79
EV/FCF Ratio	-0.42	-0.22	-1.23	-4.41
Debt / Equity Ratio	0.12	0.12	0.00	-
Debt / EBITDA Ratio	-0.56	-0.60	0.00	-
Debt / FCF Ratio	-0.60	-0.72	0.00	-
Quick Ratio	29.83	18.79	22.73	37.74
Current Ratio	30.20	19.01	23.08	38.60
Interest Coverage	-34.38	-89.14	-	-
Return on Equity (ROE)	-22.90%	-23.40%	-21.20%	-131.10%
Return on Assets (ROA)	-20.80%	-21.80%	-20.60%	-69.30%
Return on Capital (ROIC)	-22.48%	-20.51%	-23.95%	-8.70%
Earnings Yield	-32.44%	-23.55%	-19.39%	-36.77%
FCF Yield	-29.45%	-19.37%	-15.98%	-6.58%
Buyback Yield / Dilution	-45.79%	-19.72%	-102.43%	-4685.58%
Total Shareholder Return	-45.79%	-19.72%	-102.43%	-4685.58%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).